Antitrust regulators are proposing updated rules for merger review that would require companies to provide additional information about proposed deals, likely slowing down the rapid pace of healthcare transactions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,